Xintian Pharma(SZ:002873) Xin Lang Cai Jing·2025-08-25 02:47Company Overview - Xintian Pharmaceutical Co., Ltd. is located in Guiyang, Guizhou Province, established on August 11, 1995, and listed on May 19, 2017. The company specializes in the research, production, and sales of traditional Chinese medicine [1][2]. Financial Performance - For the first half of 2025, Xintian Pharmaceutical reported revenue of 358 million yuan, a year-on-year decrease of 18.88%, and a net profit attributable to shareholders of 5.77 million yuan, down 80.99% year-on-year [2]. - The company has distributed a total of 127 million yuan in dividends since its A-share listing, with 61.87 million yuan distributed over the past three years [3]. Stock Performance - As of August 25, Xintian Pharmaceutical's stock price increased by 2.23% to 12.83 yuan per share, with a total market capitalization of 3.132 billion yuan. The stock has risen 36.87% year-to-date but has seen a decline of 7.10% over the past five trading days [1]. - The company has appeared on the "Dragon and Tiger List" twice this year, with the most recent appearance on August 20, where it recorded a net purchase of 56.33 million yuan [1]. Shareholder Information - As of August 8, the number of shareholders increased to 32,800, a rise of 36.29%, while the average circulating shares per person decreased by 26.63% to 7,272 shares [2]. - Notably, the fifth-largest circulating shareholder is the Nuoan Multi-Strategy Mixed A fund, which holds 1.0731 million shares as a new shareholder [3].